Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3695852016 | Product containing precisely dinoprostone 800 microgram/1 milliliter conventional release vaginal gel (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3695854015 | Dinoprostone 800 microgram/mL vaginal gel | en | Synonym (core metadata concept) | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely dinoprostone 800 microgram/1 milliliter conventional release vaginal gel (clinical drug) | Is a | Dinoprostone-containing product in vaginal dose form | false | Inferred relationship | Some | ||
| Product containing precisely dinoprostone 800 microgram/1 milliliter conventional release vaginal gel (clinical drug) | Has active ingredient | Prostaglandin PGE>2< | false | Inferred relationship | Some | ||
| Product containing precisely dinoprostone 800 microgram/1 milliliter conventional release vaginal gel (clinical drug) | Has active ingredient | Prostaglandin E>1< | false | Inferred relationship | Some | ||
| Product containing precisely dinoprostone 800 microgram/1 milliliter conventional release vaginal gel (clinical drug) | Has active ingredient | Dinoprostone (substance) | false | Inferred relationship | Some | ||
| Product containing precisely dinoprostone 800 microgram/1 milliliter conventional release vaginal gel (clinical drug) | Has active ingredient | Posterior pituitary hormone | false | Inferred relationship | Some | ||
| Product containing precisely dinoprostone 800 microgram/1 milliliter conventional release vaginal gel (clinical drug) | Has active ingredient | Alprostadil | false | Inferred relationship | Some | ||
| Product containing precisely dinoprostone 800 microgram/1 milliliter conventional release vaginal gel (clinical drug) | Has manufactured dose form | Vaginal dose form (dose form) | false | Inferred relationship | Some | ||
| Product containing precisely dinoprostone 800 microgram/1 milliliter conventional release vaginal gel (clinical drug) | Has manufactured dose form | Vaginal gel | true | Inferred relationship | Some | ||
| Product containing precisely dinoprostone 800 microgram/1 milliliter conventional release vaginal gel (clinical drug) | Has basis of strength substance (attribute) | Dinoprostone (substance) | true | Inferred relationship | Some | 1 | |
| Product containing precisely dinoprostone 800 microgram/1 milliliter conventional release vaginal gel (clinical drug) | Has concentration strength denominator value | 1 | false | Inferred relationship | Some | 1 | |
| Product containing precisely dinoprostone 800 microgram/1 milliliter conventional release vaginal gel (clinical drug) | Has concentration strength numerator unit | mcg | true | Inferred relationship | Some | 1 | |
| Product containing precisely dinoprostone 800 microgram/1 milliliter conventional release vaginal gel (clinical drug) | Has precise active ingredient | Dinoprostone (substance) | true | Inferred relationship | Some | 1 | |
| Product containing precisely dinoprostone 800 microgram/1 milliliter conventional release vaginal gel (clinical drug) | Has concentration strength numerator value | 800 | false | Inferred relationship | Some | 1 | |
| Product containing precisely dinoprostone 800 microgram/1 milliliter conventional release vaginal gel (clinical drug) | Count of base of active ingredient | 1 | false | Inferred relationship | Some | ||
| Product containing precisely dinoprostone 800 microgram/1 milliliter conventional release vaginal gel (clinical drug) | Has concentration strength denominator unit | mL | true | Inferred relationship | Some | 1 | |
| Product containing precisely dinoprostone 800 microgram/1 milliliter conventional release vaginal gel (clinical drug) | Is a | Dinoprostone only product in vaginal dose form | true | Inferred relationship | Some | ||
| Product containing precisely dinoprostone 800 microgram/1 milliliter conventional release vaginal gel (clinical drug) | Plays role | Oxytocic therapeutic role (role) | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR